291 related articles for article (PubMed ID: 12660567)
1. [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].
Gherardi RK
Rev Neurol (Paris); 2003 Feb; 159(2):162-4. PubMed ID: 12660567
[TBL] [Abstract][Full Text] [Related]
2. Vocal fold deposits in macrophagic myofasciitis.
Glynn F; O'Sullivan P
Ear Nose Throat J; 2007 Apr; 86(4):238-9. PubMed ID: 17500400
[TBL] [Abstract][Full Text] [Related]
3. [Vaccine adjuvants and macrophagic myofasciitis].
Siegrist CA
Bull Acad Natl Med; 2003; 187(8):1511-8; discussion 1519-21. PubMed ID: 15146582
[TBL] [Abstract][Full Text] [Related]
4. Macrophagic myofasciitis in children is a localized reaction to vaccination.
Lach B; Cupler EJ
J Child Neurol; 2008 Jun; 23(6):614-9. PubMed ID: 18281624
[TBL] [Abstract][Full Text] [Related]
5. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome.
Exley C; Swarbrick L; Gherardi RK; Authier FJ
Med Hypotheses; 2009 Feb; 72(2):135-9. PubMed ID: 19004564
[TBL] [Abstract][Full Text] [Related]
6. [Vaccine adjuvants and macrophagic myofasciitis].
Siegrist CA
Arch Pediatr; 2005 Jan; 12(1):96-101. PubMed ID: 15653065
[TBL] [Abstract][Full Text] [Related]
7. Macrophagic myofasciitis in childhood: a controversial entity.
Rivas E; Gómez-Arnáiz M; Ricoy JR; Mateos F; Simón R; García-Peñas JJ; Garcia-Silva MT; Martín E; Vázquez M; Ferreiro A; Cabello A
Pediatr Neurol; 2005 Nov; 33(5):350-6. PubMed ID: 16243223
[TBL] [Abstract][Full Text] [Related]
8. Gulf war illness, post-HPV vaccination syndrome, and Macrophagic Myofasciitis. Similar disabling conditions possibly linked to vaccine-induced autoimmune dysautonomia.
Martinez-Lavin M; Tejada-Ruiz M
Autoimmun Rev; 2020 Sep; 19(9):102603. PubMed ID: 32659478
[TBL] [Abstract][Full Text] [Related]
9. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.
Gherardi RK; Coquet M; Cherin P; Belec L; Moretto P; Dreyfus PA; Pellissier JF; Chariot P; Authier FJ
Brain; 2001 Sep; 124(Pt 9):1821-31. PubMed ID: 11522584
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system disease in patients with macrophagic myofasciitis.
Authier FJ; Cherin P; Creange A; Bonnotte B; Ferrer X; Abdelmoumni A; Ranoux D; Pelletier J; Figarella-Branger D; Granel B; Maisonobe T; Coquet M; Degos JD; Gherardi RK
Brain; 2001 May; 124(Pt 5):974-83. PubMed ID: 11335699
[TBL] [Abstract][Full Text] [Related]
11. Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system.
Gherardi RK; Crépeaux G; Authier FJ
Autoimmun Rev; 2019 Jul; 18(7):691-705. PubMed ID: 31059838
[TBL] [Abstract][Full Text] [Related]
12. Distinctive clinical features in arthro-myalgic patients with and without aluminum hydroxyde-induced macrophagic myofasciitis: an exploratory study.
Ragunathan-Thangarajah N; Le Beller C; Boutouyrie P; Bassez G; Gherardi RK; Laurent S; Authier FJ
J Inorg Biochem; 2013 Nov; 128():262-6. PubMed ID: 23921285
[TBL] [Abstract][Full Text] [Related]
13. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction.
Couette M; Boisse MF; Maison P; Brugieres P; Cesaro P; Chevalier X; Gherardi RK; Bachoud-Levi AC; Authier FJ
J Inorg Biochem; 2009 Nov; 103(11):1571-8. PubMed ID: 19748679
[TBL] [Abstract][Full Text] [Related]
14. Infection and vaccination in chronic fatigue syndrome: myth or reality?
Appel S; Chapman J; Shoenfeld Y
Autoimmunity; 2007 Feb; 40(1):48-53. PubMed ID: 17364497
[TBL] [Abstract][Full Text] [Related]
15. Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease.
Gherardi RK; Aouizerate J; Cadusseau J; Yara S; Authier FJ
Morphologie; 2016 Jun; 100(329):85-94. PubMed ID: 26948677
[TBL] [Abstract][Full Text] [Related]
16. Chronic fatigue syndrome in patients with macrophagic myofasciitis.
Authier FJ; Sauvat S; Champey J; Drogou I; Coquet M; Gherardi RK
Arthritis Rheum; 2003 Feb; 48(2):569-70. PubMed ID: 12571868
[No Abstract] [Full Text] [Related]
17. Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease.
Israeli E; Agmon-Levin N; Blank M; Shoenfeld Y
Clin Rev Allergy Immunol; 2011 Oct; 41(2):163-8. PubMed ID: 20882368
[TBL] [Abstract][Full Text] [Related]
18. Atypical presentation of macrophagic myofasciitis 10 years post vaccination.
Ryan AM; Bermingham N; Harrington HJ; Keohane C
Neuromuscul Disord; 2006 Dec; 16(12):867-9. PubMed ID: 17005400
[TBL] [Abstract][Full Text] [Related]
19. Identical twins with macrophagic myofasciitis: genetic susceptibility and triggering by aluminic vaccine adjuvants?
Guis S; Mattei JP; Nicoli F; Pellissier JF; Kaplanski G; Figarella-Branger D; Manez GC; Antipoff GM; Roudier J
Arthritis Rheum; 2002 Oct; 47(5):543-5. PubMed ID: 12382305
[No Abstract] [Full Text] [Related]
20. Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey.
Verdier F; Burnett R; Michelet-Habchi C; Moretto P; Fievet-Groyne F; Sauzeat E
Vaccine; 2005 Feb; 23(11):1359-67. PubMed ID: 15661384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
